Althea Technologies Revenue and Competitors

Location

$24.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Althea Technologies's estimated annual revenue is currently $16.4M per year.(i)
  • Althea Technologies's estimated revenue per employee is $155,000
  • Althea Technologies's total funding is $24.1M.

Employee Data

  • Althea Technologies has 106 Employees.(i)
  • Althea Technologies grew their employee count by 0% last year.

Althea Technologies's People

NameTitleEmail/Phone
1
Manager Quality Control OperationsReveal Email/Phone
2
Office ManagerReveal Email/Phone
3
Telecom/Facilities SpecialistReveal Email/Phone
4
Complex Formulations SupervisorReveal Email/Phone
5
QA & RegulatoryReveal Email/Phone
6
Sr. Quality Control AssistantReveal Email/Phone
7
Drug Substance Manufacturing Group Lead - UpstreamReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Althea Technologies?

Althea Technologies' focus is on accelerating gene-based drug development by supporting researchers worldwide in their attempts to understand the mechanisms of disease and develop new therapeutics. The company's services include gene expression analyses using its proprietary eXpress Profiling technology, custom genomic analyses using real-time PCR, and cGMP plasmid DNA production for genetic vaccine and gene therapy products. For more information, visit www.altheatech.com.

keywords:N/A

$24.1M

Total Funding

106

Number of Employees

$16.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Althea Technologies News

2022-04-06 - Castle Biosciences acquiring mental health testing co ...

... and manufacturing services company Althea Technologies Inc., which was acquired by Ajinomoto Co. in a $175 million deal the same year.

2022-04-06 - Biopharmaceutical Contract Manufacturing Market to reach US$ 18.7 Billion by 2029 - Comprehensive Research Report by FMI

... access to expensive technologies, and greater flexibility are some advantages offered by ... Ajinomoto Althea Inc. (Ajinomoto Co., Inc.).

2022-04-06 - IDEAYA Biosciences Appoints Catherine Mackey, Ph.D., to its ...

... YM Biosciences and Althea Technologies. "Catherine's extensive oncology research and development experience will be invaluable to IDEAYA...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.6M1068%N/A
#2
$29.3M1065%N/A
#3
$24.1M1065%N/A
#4
$15M1068%N/A
#5
$19.1M1067%N/A